Prescription drug · ANDA
Aripiprazole NDC 71205-392
Aripiprazole 5 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-392-30 | 71205039230 | 30 TABLET in 1 BOTTLE (71205-392-30)Marketed from Jan 30, 2020 | |
| 71205-392-60 | 71205039260 | 60 TABLET in 1 BOTTLE (71205-392-60)Marketed from Jan 30, 2020 | |
| 71205-392-90 | 71205039290 | 90 TABLET in 1 BOTTLE (71205-392-90)Marketed from Jan 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aripiprazole
- Generic name (nonproprietary)
- aripiprazole
- Active ingredients
- Aripiprazole — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203908
- Marketing start
- Listing expires
- Identifiers
- Product ID 71205-392_ced62de0-d150-4ff8-a1ab-38ef67c8f061SPL ID ced62de0-d150-4ff8-a1ab-38ef67c8f061SPL set ID 11202c0a-7401-41c9-b1e7-d93739fcd36fRxCUI 402131UNII 82VFR53I78UPC 0371205392307
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205039230followed by a unit qualifier and the quantityPackage 71205-0392-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Aripiprazole tablets are indicated for the treatment of: • Schizophrenia [see Clinical Studies (14.1) ] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.’s ABILIFY ® (aripiprazole) product. However, due to Otsuka America Pharmaceutical, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Aripiprazole is an atypical antipsychotic. The oral formulation is indicated for: • Schizophrenia (14.1)
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203908
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | A-S Medication Solutions | 50090-6403 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-662 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-661 |
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-666 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-663 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-664 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Aurobindo Pharma Limited | 65862-665 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4745 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Proficient Rx LP | 71205-480 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Proficient Rx LP | 82804-023 |
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | A-S Medication Solutions | 50090-7564 |
| Aripiprazole | Aripiprazole 20 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1364 |